Gene expression profiles highlight adaptive brain mechanisms in corticotropin releasing factor overexpressing mice

Molecular Brain Research

Volumn 129, Issue 1-2, 2004, Pages 135-150

  Peeters, Pieter J ^a   Fierens, Frederik L P ^a   Van Den Wyngaert, Ilse ^a   Goehlmann, Hinrich W ^a   Swagemakers, Sigrid M ^a   Kass, Stefan U ^a   Langlois, Xavier ^a   Pullan, Shirley ^a   Stenzel Poore, Mary P ^b   Steckler, Thomas ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

CRF; Glucocorticoid; Microarray; Neurotensin; Quantitative PCR; R121919; Receptor autoradiography; Spectral map analysis; Transgenic

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; BREVICAN; CORTICOTROPIN RELEASING FACTOR; DECORIN; FK 506 BINDING PROTEIN 5; GLUCOCORTICOID; GLUCOCORTICOID KINASE; MESSENGER RNA; MYELIN; MYELIN ASSOCIATED GLYCOPROTEIN; NEUROTENSIN RECEPTOR 1; NEUROTENSIN RECEPTOR 2; PHOSPHOTRANSFERASE; PROTEIN; PROTEIN EDG2; PROTEIN FGFR2; UNCLASSIFIED DRUG;

ADAPTATION; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; BRAIN REGION; CELL PROLIFERATION; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HOMEOSTASIS; LIMBIC CORTEX; MALE; MOUSE; MYELINATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; STRESS; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; BRAIN; CALCIUM; CORTICOTROPIN-RELEASING HORMONE; GENE EXPRESSION PROFILING; HOMEOSTASIS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEUROTENSIN; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL;

ANIMALIA; MUS MUSCULUS;

EID: 4644282230     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2004.06.038     Document Type: Article

References (57)

1. G. Aguilera, C. Rabadan-Diehl, and M. Nikodemova Regulation of pituitary corticotropin releasing hormone receptors Peptides 22 2001 769 774
2. D. Amaratunga, and J. Cabrera Analysis of data from viral DNA microchips J. Am. Stat. Assoc. 96 2001 1161 1170
3. K.L. Brunson, D.E. Grigoriadis, M.T. Lorang, and T.Z. Baram Corticotropin-releasing hormone (CRH) downregulates the function of its receptor (CRF1) and induces CRF1 expression in hippocampal and cortical regions of the immature rat brain Exp. Neurol. 176 2002 75 86
4. 2+-binding proteins Biochem. J. 353 2001 1 12
5. D.T. Chalmers, T.W. Lovenberg, and E.B. De Souza Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression J. Neurosci. 15 1995 6340 6350
6. S. Chapman, P. Schenk, K. Kazan, and J. Manners Using biplots to interpret gene expression patterns in plants Bioinformatics 18 2002 202 204
7. T.H. Davies, Y.M. Ning, and E.R. Sanchez A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins J. Biol. Chem. 277 2002 4597 4600
8. W.B. Denny, D.L. Valentine, P.D. Reynolds, D.F. Smith, and J.G. Scammell Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding Endocrinology 141 2000 4107 4113
9. E. Donato di Paola, B. Cusack, M. Yamada, and E. Richelson Desensitization and down-regulation of neurotensin receptors in murine neuroblastoma clone N1Eâ€"115 by [d-Lys8] neurotensin(8â €"13) J. Pharmacol. Exp. Ther. 264 1993 1 5
10. G. Drolet, E.C. Dumont, I. Gosselin, R. Kinkead, S. Laforest, and J.F. Trottier Role of endogenous opioid system in the regulation of the stress response Prog. Neuro-Psychopharmacol. Biol. Psychiatry 25 2001 729 741
11. E. Fuchs, and G. Flugge Modulation of binding sites for corticotropin-releasing hormone by chronic psychosocial stress Psychoneuroendocrinology 20 1995 33 51
12. L. Givalois, F. Marmigere, F. Rage, G. Ixart, S. Arancibia, and L. Tapia-Arancibia Immobilization stress rapidly and differentially modulates BDNF and TrkB mRNA expression in the pituitary gland of adult male rats Neuroendocrinology 74 2001 148 159
13. H.J. Harris, Y. Kotelevtsev, J.J. Mullins, J.R. Seckl, and M.C. Holmes Intracellular regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase (11beta-HSD)-1 plays a key role in regulation of the hypothalamicâ€"pituitaryâ€"adrenal axis: analysis of 11beta-HSD-1-deficient mice Endocrinology 142 2001 114 120
14. R.L. Hauger, and G. Aguilera Regulation of pituitary corticotropin releasing hormone (CRH) receptors by CRH: interaction with vasopressin Endocrinology 133 1993 1708 1714
15. R.L. Hauger, R.D. Smith, S. Braun, F.M. Dautzenberg, and K.J. Catt Rapid agonist-induced phosphorylation of the human CRF receptor, type 1: a potential mechanism for homologous desensitization Biochem. Biophys. Res. Commun. 268 2000 572 576
16. S.C. Heinrichs Behavioral consequences of altered corticotropin-releasing factor activation in brain: a functionalist view of affective neuroscience T. Steckler N. Kalin J.M. Reul Handbook on Stress and the Brain 2004 Elsevier Amsterdam
17. S.C. Heinrichs, E.B. De Souza, G. Schulteis, J.L. Lapsansky, and D.E. Grigoriadis Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist Neuropsychopharmacology 27 2002 194 202
18. E. Hermans, and J.M. Maloteaux Mechanisms of regulation of neurotensin receptors Pharmacol. Ther. 79 1998 89 104
19. E. Hermans, M.A. Vanisberg, M. Geurts, and J.M. Maloteaux Down-regulation of neurotensin receptors after ligand-induced internalization in rat primary cultured neurons Neurochem. Int. 31 1997 291 299
20. A.R. Hoffman, G. Ceda, and T.D. Reisine Corticotropin-releasing factor desensitization of adrenocorticotropic hormone release is augmented by arginine vasopressin J. Neurosci. 5 1985 234 242
21. A. Holmes, M. Heilig, N.M. Rupniak, T. Steckler, and G. Griebel Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders Trends Pharmacol. Sci. 24 2003 580 588
22. H.E. Kunzel, A.W. Zobel, T. Nickel, N. Ackl, M. Uhr, A. Sonntag, M. Ising, and F. Holsboer Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects J. Psychiatr. Res. 37 2003 525 533
23. J. Landgrebe, W. Wurst, and G. Welzl Permutation-validated principal components analysis of microarray data Genome Biol. 3 2002 R1 R19
24. J. Leibrock, F. Lottspeich, A. Hohn, M. Hofer, B. Hengerer, P. Masiakowski, H. Thoenen, and Y.A. Barde Molecular cloning and expression of brain-derived neurotrophic factor Nature 314 1989 149 152
25. P.J. Lewi Spectral mapping, a technique for classifying biological activity profiles of chemical compounds Arzneim.-Forsch. 26 1976 1295 1300
26. J.K. Mai, J. Triepel, and J. Metz Neurotensin in the human brain Neuroscience 22 1987 499 524
27. J. Mazella, J.M. Botto, E. Guillemare, T. Coppola, P. Sarret, and J.P. Vincent Structure, functional expression, and cerebral localization of the levocabastine-sensitive neurotensin/neuromedin N receptor from mouse brain J. Neurosci. 16 1996 5613 5620
28. J. Mazella, N. Zsurger, V. Navarro, J. Chabry, M. Kaghad, D. Caput, P. Ferrara, N. Vita, D. Gully, J.P. Maffrand, and J.P. Vincent The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor J. Biol. Chem. 273 1998 26273 26276
29. 125I]Tyr3- neurotensin Neuroscience 22 1987 525 536
30. A. Naray-Fejes-Toth, G. Fejes-Toth, K.A. Volk, and J.B. Stokes SGK is a primary glucocorticoid-induced gene in the human J. Steroid Biochem. Mol. Biol. 75 2000 51 56
31. V. Navarro, S. Martin, P. Sarret, M.S. Nielsen, C.M. Petersen, J. Vincent, and J. Mazella Pharmacological properties of the mouse neurotensin receptor 3. Maintenance of cell surface receptor during internalization of neurotensin FEBS Lett. 495 2001 100 105
32. A. Nicot, W. Rostene, and A. Berod Hypercorticism induces neurotensin mRNA in rat periventricular hypothalamus NeuroReport 6 1995 2158 2160
33. A. Nicot, W.B. Rowe, E.R. de Kloet, C. Betancur, D.S. Jessop, S.L. Lightman, R. Quirion, W. Rostene, and A. Berod Endogenous neurotensin regulates hypothalamicâ€"pituitaryâ€"adrenal axis activity and peptidergic neurons in the rat hypothalamic paraventricular nucleus J. Neuroendocrinol. 9 1997 263 269
34. H. Ohata, K. Arai, and T. Shibasaki Effect of chronic administration of a CRF(1) receptor antagonist, CRA1000, on locomotor activity and endocrine responses to stress Eur. J. Pharmacol. 457 2002 201 206
35. T. Reisine, and A. Hoffman Desensitization of corticotropin-releasing factor receptors Biochem. Biophys. Res. Commun. 111 1983 919 925
36. W. Rowe, V. Viau, M.J. Meaney, and R. Quirion Stimulation of CRH-mediated ACTH secretion by central administration of neurotensin: evidence for the participation of the paraventricular nucleus J. Neuroendocrinol. 7 1995 109 117
37. P. Sarret, P. Krzywkowski, L. Segal, M.S. Nielsen, C.M. Petersen, J. Mazella, T. Stroh, and A. Beaudet Distribution of NTS3 receptor/sortilin mRNA and protein in the rat central nervous system J. Comp. Neurol. 461 2003 483 505
38. J.G. Scammell, W.B. Denny, D.L. Valentine, and D.F. Smith Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three New World primates Gen. Comp. Endocrinol. 124 2001 152 165
39. V. Scarceriaux, D. Pelaprat, P. Forgez, A.M. Lhiaubet, and W. Rostene Effects of dexamethasone and forskolin on neurotensin production in rat hypothalamic cultures Endocrinology 136 1995 2554 2560
40. V. Scarceriaux, F. Souaze, C.M. Bachelet, P. Forgez, E. Bourdel, J. Martinez, W. Rostene, and D. Pelaprat Neurotensin receptor down-regulation induced by dexamethasone and forskolin in rat hypothalamic cultures is mediated by endogenous neurotensin J. Neuroendocrinol. 8 1996 587 593
41. M.A. Smith, S. Makino, S.Y. Kim, and R. Kvetnansky Stress increases brain-derived neurotropic factor messenger ribonucleic acid in the hypothalamus and pituitary Endocrinology 136 1995 3743 3750
42. F. Souaze, W. Rostene, and P. Forgez Neurotensin agonist induces differential regulation of neurotensin receptor mRNA. Identification of distinct transcriptional and post-transcriptional mechanisms J. Biol. Chem. 272 1997 10087 10094
43. M.P. Stenzel-Poore, V.A. Camferon, J. Vaughan, P.E. Sawchenko, and W. Vale Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice Endocrinology 130 1992 3378 3386
44. M.P. Stenzel-Poore, S.C. Heinrichs, S. Rivest, G.F. Koob, and W.W. Vale Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior J. Neurosci. 14 1994 2579 2584
45. J.D. Storey, and R. Tibshirani Statistical significance for genomewide studies Proc. Natl. Acad. Sci. U. S. A. 100 2003 9440 9445
46. J.T. Turner, M.R. James-Kracke, and J.M. Camden Regulation of the neurotensin receptor and intracellular calcium mobilization in HT29 cells J. Pharmacol. Exp. Ther. 253 1990 1049 1056
47. V.G. Tusher, R. Tibshirani, and G. Chu Significance analysis of microarrays applied to the ionizing radiation response Proc. Natl. Acad. Sci. U. S. A. 98 2001 5116 5121
48. M.M. van Gaalen, M.P. Stenzel-Poore, F. Holsboer, and T. Steckler Effects of transgenic overproduction of CRH on anxiety-like behaviour Eur. J. Neurosci. 15 2002 2007 2015
49. M.M. van Gaalen, M. Stenzel-Poore, F. Holsboer, and T. Steckler Reduced attention in mice overproducing corticotropin-releasing hormone Behav. Brain Res. 142 2003 69 79
50. K. Van Pett, V. Viau, J.C. Bittencourt, R.K. Chan, H.Y. Li, C. Arias, G.S. Prins, M. Perrin, W. Vale, and P.E. Sawchenko Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse J. Comp. Neurol. 428 2000 191 212
51. J.P. Vincent, J. Mazella, and P. Kitabgi Neurotensin and neurotensin receptors Trends Pharmacol. Sci. 20 1999 302 309
52. M.K. Webster, L. Goya, Y. Ge, A.C. Maiyar, and G.L. Firestone Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum Mol. Cell. Biol. 13 1993 2031 2040
53. P.C. White, T. Mune, and A.K. Agarwal 11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess Endocr. Rev. 18 1997 135 156
54. L. Wouters, H.W. Gohlmann, L. Bijnens, S.U. Kass, G. Molenberghs, and P.J. Lewi Graphical exploration of gene expression data: a comparative study of three multivariate methods Biometrics 59 2003 1131 1139
55. M. Yamada, M. Yamada, and E. Richelson Further characterization of neurotensin receptor desensitization and down-regulation in clone N1Eâ€"115 neuroblastoma cells Biochem. Pharmacol. 45 1993 2149 2154
56. A.W. Zobel, T. Nickel, H.E. Kunzel, N. Ackl, A. Sonntag, M. Ising, and F. Holsboer Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated J. Psychiatr. Res. 34 2000 171 181
57. P.J. Peeters, H.W. Gohlmann, I. Van Den Wyngaert, S.M. Swagemakers, L. Bijnens, S.U. Kass, and T. Steckler Transcriptional response to corticotropin-releasing factor in AtT-20 cells Mol. Pharmacol. 2004 (in press)